MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1111/jvh.70035

Медицинская библиотека · Journal of viral hepatitis · 2025

Increasing Treatment Uptake for Chronic Hepatitis B in South America: A Comparative Analysis of Country-Specific and WHO 2024 Guidelines.

Mendizabal Manuel, Sabate Constanza D, González Ballerga Esteban, Gruz Fernando, Ridruejo Ezequiel, Soza Alejandro, Poniachik Jaime, Vergara Grace, Mainardi Victoria, Mezzano Gabriel, Bessone Fernando, Anders Margarita, Pessoa Mario G, Cairo Fernando, Chiodi Daniela, Dirchwolf Melisa, Cheinquer Hugo, Susana Melina, Rondeau Luis, Rifrani Gabriel, Aguirre Herman, Hernandez Nelia, Enrique Carla, Navarro Lucia, Labaronnie Eugenia, Zitelli Patricia M, de Araujo Alexandre, Olivetti Antonella, Simian Daniela, Giunta Diego, Silva Marcelo, Marciano Sebastián

СтатьяСравнительное исследованиеПеревод в очереди

Аннотация

The 2024 WHO guidelines for chronic hepatitis B (CHB) aim to expand and simplify treatment eligibility. We aimed to estimate treatment eligibility and uptake according to country-specific guidelines and evaluate treatment expansion based on the WHO guidelines. Treatment-naïve CHB patients from Argentina, Brazil, Chile and Uruguay referred to evaluation between January 2010 and June 2024 were retrospectively included. Treatment candidacy was evaluated according to both country-specific and WHO guidelines. A total of 719 patients with CHB, treatment naïve, were included (67.1% male; median age: 50.4 years; HBeAg-positive: 36.3%). The median HBV-DNA level was 43,000 (IQR 633-110,000,000) IU/mL, median ALT was 41 (IQR 23-99) U/L, 47.0% had an APRI > 0.5 and 21.1% had cirrhosis. According to country-specific guidelines, 56.9% (95% CI: 53.2-60.5) met the criteria for treatment. Antiviral treatment was initiated in 84.3% of eligible patients. The proportion of patients meeting treatment criteria under the WHO guidelines increased to 67.3% (95% CI: 63.8-70.6), resulting in a 10.4% (95% CI: 8.1-12.8) increase in treatment candidacy. Treatment expansion was significantly higher in women (15.2%; 95% CI: 10.2-20.1) than in men (8.1%; 95% CI: 5.4-10.7). According to WHO guidelines, a considerable proportion of CHB patients who do not meet country-specific criteria are eligible for antiviral therapy. Implementing WHO criteria can enhance treatment rates and advance efforts toward CHB elimination.

Для цитирования: Mendizabal Manuel, Sabate Constanza D, González Ballerga Esteban, Gruz Fernando, Ridruejo Ezequiel, Soza Alejandro, Poniachik Jaime, Vergara Grace, Mainardi Victoria, Mezzano Gabriel, Bessone Fernando, Anders Margarita, Pessoa Mario G, Cairo Fernando, Chiodi Daniela, Dirchwolf Melisa, Cheinquer Hugo, Susana Melina, Rondeau Luis, Rifrani Gabriel, Aguirre Herman, Hernandez Nelia, Enrique Carla, Navarro Lucia, Labaronnie Eugenia, Zitelli Patricia M, de Araujo Alexandre, Olivetti Antonella, Simian Daniela, Giunta Diego, Silva Marcelo, Marciano Sebastián. Increasing Treatment Uptake for Chronic Hepatitis B in South America: A Comparative Analysis of Country-Specific and WHO 2024 Guidelines.. Journal of viral hepatitis. 2025. DOI: 10.1111/jvh.70035.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.